Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Alkermes, Inc.
Age
16–70
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Willing and able to give informed consent/assent as per local requirements
Agrees to use an acceptable method of contraception during the study, and for 30 days after any study drug administration, unless surgically sterile or post-menopausal
Has the potential to benefit from the administration of ALKS 3831, in the opinion of the investigator
Subject met the eligibility criteria of the antecedent study at the time of enrollment in the antecedent study and completed the treatment period in one of the following antecedent studies within 7 days: ALK3831-A304, ALK3831-A306, or ALK3831-A307
Additional criteria may apply
You may not be if
Has any finding that, in the view of the investigator or medical monitor, would compromise the safety of the subject or affect their ability to fulfill the protocol visit schedule or visit requirements
Has a positive drug screen for drugs of abuse at study entry
Currently pregnant or breastfeeding or is planning to become pregnant during the study or within 30 days of the last study drug administration
